NCT06738225Not yet recruiting
Serum MicroRNAs as Diagnostic Biomarkers of Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 27 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
evaluation the diagnostic value of certain MicroRNAs as biomarkers of Colorectal cancer by comparing its expression levels in Colorectal cancer patients and normal individuals.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 12 Dec 2024
- Start date
- 1 Mar 2025
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Bishoy Shehata
- Diseases
- Colorectal cancer
- NCT number
- NCT06738225
What you commit to
- Study type: Observational
- Planned participants: 80
- From 1 Mar 2025 to the primary completion date, 1 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with prior history of CRC.
Other
- Patients with secondary tumors or metastasis originating from non-colorectal sources.
- Patients who refuse to contribute in this study.
Who the study is looking for
- Adults (age 18-75) diagnosed with primary CRC (histopathologically confirmed).
- CRC patients who have not received prior treatment (i.e., chemotherapy or radiation).
- Age-matched healthy controls without colorectal disease
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.